Página principal601607 • SHA
add
Shanghai Pharmaceuticals Holding Ord Shs A
Cierre anterior
¥18.17
Intervalo del día
¥18.06 - ¥18.29
Intervalo anual
¥15.36 - ¥23.98
Cap. bursátil
60.29 mil M CNY
Volumen prom.
13.45 M
Relación precio‑beneficio
17.55
Rendimiento por dividendos
-
Mercado primario
SHA
Noticias del mercado
Finanzas
Estado de ingresos
Ingresos
Ingresos netos
(CNY) | mar 2024info | Cambio interanual |
---|---|---|
Ingresos | 70.15 mil M | 5.93% |
Gastos de operación | 5650.36 M | -4.06% |
Ingresos netos | 1542.28 M | 1.62% |
Margen de utilidad neta | 2.20 | -3.93% |
Ganancias por acción | — | — |
EBITDA | 2713.03 M | -13.23% |
Tasa impositiva vigente | 22.80% | — |
Balance general
Activos totales
Pasivos totales
(CNY) | mar 2024info | Cambio interanual |
---|---|---|
Inversiones plazo/efectivo | 37.18 mil M | -2.45% |
Activos totales | 217.42 mil M | 5.52% |
Pasivos totales | 135.33 mil M | 7.27% |
Acciones totales | 82.09 mil M | — |
Acciones en circulación | 3703.30 M | — |
Precio/valor contable | 0.96 | — |
Rendimiento de los activos | 2.77% | — |
Rendimiento del capital | 4.41% | — |
Flujo de efectivo
Variación neta en caja
(CNY) | mar 2024info | Cambio interanual |
---|---|---|
Ingresos netos | 1542.28 M | 1.62% |
Efectivo de operaciones | -5473.60 M | -108.65% |
Efectivo de inversiones | 1841.73 M | 187.44% |
Efectivo de financiación | 3250.25 M | -24.64% |
Variación neta en caja | -373.88 M | 12.88% |
Flujo de efectivo libre | -7831.72 M | -33.74% |
Acerca de
Shanghai Pharmaceuticals is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Fecha de fundación
18 ene 1994
Sitio web
Cantidad de empleados
48,164